Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06332950
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-27
First Post:
2024-03-20
Brief Title:
Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome II With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy
Sponsor:
Organization:
Shanghai Chest Hospital